Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment.

ABSTRACT:

Background

Aromatase inhibitor (AI)-induced joint pain is a common toxicity of AI treatment. Although many studies have been conducted to examine the occurrence and severity of AI-induced joint pain in breast cancer survivors, none of the studies focused on the Chinese population with breast cancer. Given that the differences in cultural background and the genetic structure between Asians and Caucasians may contribute to different phenotypes of joint pain, this cross-sectional study was therefore conducted to examine the prevalence of AI-induced joint pain among Chinese breast cancer survivors receiving AI treatment and the correlates of pain.

Methods

This cross-sectional study was conducted in a tertiary hospital in China. Breast cancer survivors undergoing AI treatment wer

SUBMITTER: Wang T 

PROVIDER: S-EPMC9633515 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature